Trademark: THE BRIDGE HATTR AMYLOIDOSIS
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
THE BRIDGE HATTR AMYLOIDOSIS
Click here to search for trademarks similar to THE BRIDGE HATTR AMYLOIDOSIS
Proof of use for THE BRIDGE HATTR AMYLOIDOSIS
We do not have any records of a proof of use for THE BRIDGE HATTR AMYLOIDOSIS at this moment.
Click here to add a proof of use for THE BRIDGE HATTR AMYLOIDOSIS
Possible trademark infringements of THE BRIDGE HATTR AMYLOIDOSIS
Basic Information about THE BRIDGE HATTR AMYLOIDOSIS
- Serial Number
- 87795814
- Filing Date
- 13 Feb 2018
- Registration Number
- 5665054
- Registration Date
- 29 Jan 2019
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of THE BRIDGE HATTR AMYLOIDOSIS on the blockchain with WikiTrademarks.io.
- First use of THE BRIDGE HATTR AMYLOIDOSIS anywhere
- THE BRIDGE HATTR AMYLOIDOSIS was first used on 30 Jun 2017 for the primary classification of goods and services, international, 035 (Advertising and business)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 035
- US Codes
- 100; 101; 102
- First use of THE BRIDGE HATTR AMYLOIDOSIS anywhere
- THE BRIDGE HATTR AMYLOIDOSIS was first used on 30 Jun 2017 for the primary classification of goods and services, international, 041 (Education and entertainment)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 041
- US Codes
- 100; 101; 107
- First use of THE BRIDGE HATTR AMYLOIDOSIS anywhere
- THE BRIDGE HATTR AMYLOIDOSIS was first used on 30 Jun 2017 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns THE BRIDGE HATTR AMYLOIDOSIS?
1. Alnylam Pharmaceuticals, Inc. Cambridge MA
2. Alnylam Pharmaceuticals, Inc. Cambridge MA
3. Alnylam Pharmaceuticals, Inc. Cambridge MA
Correspondent
- Sarah Anne Keefe Womble Bond Dickinson (US) LLP
- 470 Atlantic Avenue, Suite 600
- Boston, MA 02210
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io